Observational study / 2015
Higher sodium intake was linked to increased clinical exacerbation rates and MRI lesions in patients with multiple sclerosis.
Researchers evaluated sodium intake via urinary sodium excretion in 70 patients with relapsing-remitting multiple sclerosis followed for 2 years, with findings replicated in 52 additional MS patients. In an adjusted multivariate model, exacerbation rates were 2.75-fold higher (95% CI 1.3 to 5.8) in the medium sodium group and 3.95-fold higher (95% CI 1.4 to 11.2) in the high sodium group compared with the low-intake group. High sodium intake was also associated with a 3.4-fold greater chance of developing a new MRI lesion and an average of eight more T2 lesions. A similar relationship was observed in the independent replication group.
Shows an association, not proof of cause and effect.
- Study type
- Observational cohort study with replication cohort
- Who was studied
- 70 relapsing-remitting MS patients followed for 2 years, plus a replication group of 52 MS patients
- What was measured
- Clinical exacerbation rates and MRI radiological disease activity (new and T2 lesions)
THE PAPER
Sodium intake is associated with increased disease activity in multiple sclerosis.
Farez MF, Fiol MP, Gaitán MI, Quintana FJ, Correale J. J Neurol Neurosurg Psychiatry, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.